Biontech plans to produce mRNA vaccines in Africa

In an attempt to address covid-19 and a number of other widespread diseases in Africa, Biontech plans to establish a factory there for the production of mRNA vaccines.

Biontech CEO and co-founder Ugur Sahin | Photo: Biontech / PR

Biontech plans to expand its production to Africa by establishing an mRNA vaccine factory to combat widespread diseases including covid-19.

At the same time, the EU is moving towards strengthening the overall vaccine production of the continent, according to the Financial Times.

Read the whole article

Get 14 days free access.
No credit card required.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Orphazyme cuts guidance following FDA setback

Friday's disappointing rejection letter from the US FDA is affecting Orphazyme's guidance for 2021. Now, the biotech firm forecasts an operating deficit of DKK 670-700m, up from DKK 100-150m.

Further reading

Related articles

Latest news

See all jobs